Real-World Observational Study to Assess Drug Utilisation Patterns in the US Among Migraine Patients Treated with Lasmiditan (H8H-MC-B005)

16/03/2023
22/11/2024
EU PAS number:
EUPAS45442
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

B005 05 Protocol PASS(v0.1)_Redacted.pdf

English (4.43 MB - PDF) View document
Study results
Study report
Study report

LY573144 B005 Noninterventional PASS Final Study Report – Basic Version 1_Redacted.pdf

English (373.42 KB - PDF) View document
Other information